Skip to main content
. 2021 Jul 27;12(9):1540–1554. doi: 10.1039/d1md00125f

Selectivity profile of pyrazoline-based TZD inhibitors against a panel of human HDACs. IC50 values are means, and errors were obtained from statistical analysis of non-linear regression fits to sets of 10 data points.

IC50 (μM)
Compound HDAC1 HDAC2 HDAC3 HDAC4 HDAC6 HDAC7 HDAC8
13j 4.9 13 9.1 0.7 ± 0.3 39 >50 10 ± 1.0
14c >50 >50 >50 0.88 ± 4 7.6 >50 >50
14j 11 21 11 0.8 ± 0.2 13 6.7 25 ± 7.0